Risk of thrombosis with thrombocytopenia syndrome after COVID‐19 vaccination prior to the recognition of vaccine‐induced thrombocytopenia and thrombosis: A self‐controlled case series study in England
Abstract Background Several studies have found increased risks of thrombosis with thrombocytopenia syndrome (TTS) following the ChAdOx1 vaccination. However, case ascertainment is often incomplete in large electronic health record (EHR)‐based studies. Objectives To assess for an association between...
Main Authors: | Hannah Higgins, Nick Andrews, Julia Stowe, Gayatri Amirthalingam, Mary Ramsay, Gurpreet Bahra, Anthony Hackett, Karen A. Breen, Michael Desborough, Dalia Khan, Heather Leary, Connor Sweeney, Elizabeth Hutchinson, Susan E. Shapiro, Charlotte Lees, Jay Dhanapal, Peter K. MacCallum, Shoshana Burke, Vickie McDonald, Ngai Mun Aiman Entwistle, Stephen Booth, Christina J. Atchison, Beverley J. Hunt |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-03-01
|
Series: | Research and Practice in Thrombosis and Haemostasis |
Subjects: | |
Online Access: | https://doi.org/10.1002/rth2.12698 |
Similar Items
-
Vaccine‐induced Immune Thrombocytopenia and Thrombosis (VITT)
by: Michael Makris, et al.
Published: (2021-07-01) -
Thrombocytopenia and thrombosis in hospitalized patients with COVID-19
by: Heng Mei, et al.
Published: (2020-12-01) -
Experience of danaparoid to treat vaccine-induced immune thrombocytopenia and thrombosis, VITT
by: Lasse Myllylahti, et al.
Published: (2022-02-01) -
Vaccine-induced Thrombotic Thrombocytopenia and Graft Thrombosis in a Renal Transplant Recipient
by: P. S. Shahanas, et al.
Published: (2024-09-01) -
Severe thrombocytopenia, thrombosis and anti-PF4 antibody after Pfizer-BioNTech COVID-19 mRNA vaccine booster-Is it vaccine-induced Immune thrombotic thrombocytopenia?
by: Ling, Victor W. T., et al.
Published: (2023)